Scholar Rock Holding Corp (SRRK) stock
SRRKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$45.08+0.54 (+1.21%)
Close on Nov 17, 2026Market cap $5.49BP/E –Yield –
Scholar Rock ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Scholar Rock's ebitda for the twelve months ending Jun 30, 2026 was -$404.88M. For fiscal 2025 it was -$382.99M. The highest annual figure on record is -$24.36M in fiscal 2017.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$382.99M | – |
| FY2024 | Dec 31, 2024 | -$250.12M | – |
| FY2023 | Dec 31, 2023 | -$168.45M | – |
| FY2022 | Dec 31, 2022 | -$131.38M | – |
| FY2021 | Dec 31, 2021 | -$127.29M | – |
| FY2020 | Dec 31, 2020 | -$85.39M | – |
| FY2019 | Dec 31, 2019 | -$53.24M | – |
| FY2018 | Dec 31, 2018 | -$49.89M | – |
| FY2017 | Dec 31, 2017 | -$24.36M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$108.60M | – |
| Q1 FY2026 | Mar 31, 2026 | -$101.68M | – |
| Q4 FY2025 | Dec 31, 2025 | -$91.47M | – |
| Q3 FY2025 | Sep 30, 2025 | -$103.13M | – |
| Q2 FY2025 | Jun 30, 2025 | -$111.69M | – |
| Q1 FY2025 | Mar 31, 2025 | -$76.70M | – |
| Q4 FY2024 | Dec 31, 2024 | -$68.96M | – |
| Q3 FY2024 | Sep 30, 2024 | -$64.33M | – |
| Q2 FY2024 | Jun 30, 2024 | -$59.00M | – |
| Q1 FY2024 | Mar 31, 2024 | -$57.82M | – |
| Q4 FY2023 | Dec 31, 2023 | -$47.36M | – |
| Q3 FY2023 | Sep 30, 2023 | -$42.96M | – |
| Q2 FY2023 | Jun 30, 2023 | -$38.35M | – |
| Q1 FY2023 | Mar 31, 2023 | -$39.78M | – |
| Q4 FY2022 | Dec 31, 2022 | -$39.68M | – |
| Q3 FY2022 | Sep 30, 2022 | -$43.12M | – |
| Q2 FY2022 | Jun 30, 2022 | -$42.40M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.18M | – |
| Q4 FY2021 | Dec 31, 2021 | -$34.64M | – |
| Q3 FY2021 | Sep 30, 2021 | -$36.40M | – |
| Q2 FY2021 | Jun 30, 2021 | -$29.64M | – |
| Q1 FY2021 | Mar 31, 2021 | -$26.62M | – |
| Q4 FY2020 | Dec 31, 2020 | -$25.79M | – |
| Q3 FY2020 | Sep 30, 2020 | -$23.23M | – |
| Q2 FY2020 | Jun 30, 2020 | -$19.07M | – |
| Q1 FY2020 | Mar 31, 2020 | -$17.30M | – |
| Q4 FY2019 | Dec 31, 2019 | -$11.96M | – |
| Q3 FY2019 | Sep 30, 2019 | -$16.78M | – |
| Q2 FY2019 | Jun 30, 2019 | -$13.07M | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.43M | – |
| Q4 FY2018 | Dec 31, 2018 | -$15.32M | – |
| Q3 FY2018 | Sep 30, 2018 | -$11.03M | – |
| Q2 FY2018 | Jun 30, 2018 | -$14.70M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.84M | – |
| Q4 FY2017 | Dec 31, 2017 | -$8.29M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.78M | – |
See a number that looks wrong?